Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: Induction of CYP1B1 expression by TCDD

Volotinen M., Mäenpää J., Kankuri E., Oksala O., Pelkonen O., Nakajima M., Yokoi T., Hakkola J.

2009
Investigative Ophthalmology and Visual Science

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Institute of Biomedicine, Institute of Pharmacology, University of Helsinki, Helsinki, Finland; Santen Oy, Tampere, Finland; Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland; Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.

Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

View all Glaucoma publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022